Pre-order Enquiry
Request Free Sample
Asia Pacific Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
SKU ID : DBMR-11617936 | Publishing Date : 01-Nov-2017 | No. of pages : 350
Detailed TOC of Asia Pacific Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
TABLE OF CONTENTS1. INTRODUCTION 32
1.1. OBJECTIVES OF THE STUDY 32
1.2. MARKET DEFINITION 32
1.3. OVERVIEW OF ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET 32
1.4. CURRENCY AND PRICING 33
1.5. LIMITATION 33
1.6. MARKETS COVERED 34
2. MARKET SEGMENTATION 38
2.1. MARKETS COVERED 38
2.2. GEOGRAPHIC SCOPE 40
2.3. YEARS CONSIDERED FOR THE STUDY 41
2.4. CURRENCY AND PRICING 41
2.5. RESEARCH METHODOLOGY 42
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.7. SECONDARY SOURCES 47
2.8. ASSUMPTIONS 47
3. MARKET OVERVIEW 48
3.1. DRIVERS 49
3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION 49
3.1.2. GROWING NUMBER OF GERIATRIC POPULATION 49
3.1.3. GROWTH IN DEMAND OF TOPICAL DRUG DELIVERY DRUGS 49
3.1.4. INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT 50
3.1.5. NEW PRODUCT LAUNCHESBY KEY PLAYERS 50
3.2. RESTRAINTS 50
3.2.1. EXPIRY OF PATENT FOR DRUGS 50
3.2.2. WEAK REIMBURSEMENT POLICIES 50
3.2.3. STRINGENT REGULATORY POLICIES 51
3.3. OPPORTUNITIES 51
3.3.1. HIGH INVESTMENTS IN R&D TO INNOVATE NEW PRODUCTS 51
3.3.2. LUCRATIVE OPPORTUNITIES IN EMERGING MARKET 51
3.3.3. INCREASING MERGERS AND ACQUISITIONS 51
3.4. CHALLENGES 52
3.4.1. PRICING PRESSURE BY GOVERNMENT 52
3.4.2. SIDE EFFECTSOF TOPICAL CORTICOSTEROIDS 53
4. EXECUTIVE SUMMARY 54
5. PREMIUM INSIGHTS 56
6. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME 59
6.1. OVERVIEW 60
6.2. FLUDROXYCORTIDE 62
6.3. TRIAMCINOLONE ACETONIDE 63
6.4. FLUOCINOLONE ACETONIDE 64
6.5. ANTISEPTICS 65
6.6. BETAMETHASONE 66
6.7. CLOBETASONE PROPIONATE 67
6.8. CLOBETASONE BUTYRATE 68
6.9. HALOBETASONE 69
6.10. MOMETASONE 70
6.11. OTHERS 71
7. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS 72
7.1. OVERVIEW 73
7.2. ULTRA HIGH 75
7.2.1. CLOBETASOL PROPIONATE 76
7.2.2. DIFLORASONE DIACETATE 76
7.2.3. BETAMETHASONE DIPROPIONATE GLYCOL 76
7.3. HIGH 77
7.3.1. AMCINONIDE 78
7.3.2. BETAMETHASONE DIPROPIONATE 78
7.3.3. DESOXIMETASONE 78
7.3.4. FLUOCINONIDE 78
7.3.5. OTHERS 79
7.4. MODERATE 79
7.4.1. DESOXIMETASONE 80
7.4.2. FLUOCINOLONE ACETONIDE 80
7.4.3. FLUDROXYCORTIDE 81
7.4.4. HYDROCORTISONE VALERATE 81
7.4.5. TRIAMCINOLONE ACETONIDE 81
7.4.6. CLOBETASONE BUTYRATE 81
7.4.7. OTHERS 81
7.5. MILD 82
7.5.1. HYDROCORTISONE 83
7.5.2. HYDROCORTISONE ACETATE 83
7.5.3. BETAMETHASONE VALERATE 83
7.5.4. DESONIDE 84
7.5.5. FLUOCINOLONE ACETONIDE 84
7.5.6. OTHERS 84
8. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION 85
8.1. OVERVIEW 86
8.2. ACNE 88
8.3. DERMATITIS 89
8.4. PSORIASIS 89
8.5. SKIN INFECTION 91
8.6. HYPERPIGMENTATION 92
8.7. MELASMA 93
8.8. OTHERS 94
9. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE 95
9.1. OVERVIEW 96
9.2. OINTMENTS 98
9.3. CREAMS 99
9.4. LIQUID & SOLUTIONS 100
9.5. LOTIONS 101
9.6. GEL 102
9.7. OILS 103
9.8. PASTES 104
9.9. SPRAYS 105
9.10. OTHERS 106
10. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER 107
10.1. OVERVIEW 108
10.2. HOSPITAL 110
10.3. DERMATOLOGY CLINICS 111
10.4. HOMECARE 112
10.5. OTHERS 113
11. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET,
BY DISTRIBUTION CHANNEL 114
11.1. OVERVIEW 115
11.2. HOSPITAL PHARMACIES 117
11.3. PHARMACY STORES 118
11.4. ONLINE PHARMACIES 119
11.5. OTHERS 120
12. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE 121
12.1. OVERVIEW 122
12.2. OVER THE COUNTER (OTC) BASED 124
12.3. PRESCRIPTION BASED 125
13. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS 126
13.1. OVERVIEW 127
13.2. BETNOVATE 127
13.3. BETNOVATE N 127
13.4. PANDERM PLUS 128
13.5. LOBATE 128
13.6. COSVATE G 128
13.7. CLOP G 128
13.8. TENOVATE GN 128
13.9. LOBATE GM 128
13.10. ULTIDERM 128
13.11. FLUTIVATE 129
13.12. FEXIN 129
13.13. MOMATE 129
13.14. CANDIDERM 129
13.15. OTHERS 129
14. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY 130
14.1. OVERVIEW 131
14.2. ASIA-PACIFIC 230
14.2.1. JAPAN 242
14.2.2. CHINA 247
14.2.3. INDIA 253
14.2.4. SOUTH KOREA 259
14.2.5. AUSTRALIA 264
14.2.6. SINGAPORE 269
14.2.7. THAILAND 274
14.2.8. MALAYSIA 279
14.2.9. INDONESIA 284
14.2.10. PHILIPPINES 289
14.2.11. REST OF ASIA PACIFIC 294
15. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE 331
15.1. COMPANY SHARE ANALYSIS: ASIA PACIFIC 331
16. COMPANY PROFILES 335
16.1. GLAXOSMITHKLINE PLC. 335
16.1.1. COMPANY OVERVIEW 335
16.1.2. GLAXOSMITHKLINE PLC: REVENUE ANALYSIS 335
16.1.3. PRODUCT PORTFOLIO 336
16.1.4. RECENT DEVELOPMENTS 336
16.2. MERCK & CO. INC. 337
16.2.1. COMPANY OVERVIEW 337
16.2.2. MERCK & CO. INC.: REVENUE ANALYSIS 337
16.2.3. PRODUCT PORTFOLIO 338
16.2.4. RECENT DEVELOPMENTS 338
16.3. LEO PHARMA 339
16.3.1. COMPANY OVERVIEW 339
16.3.2. LEO PHARMA: REVENUE ANALYSIS 339
16.3.3. PRODUCT PORTFOLIO 340
16.3.4. RECENT DEVELOPMENTS 340
16.4. ALMIRALL S.A. 341
16.4.1. COMPANY OVERVIEW 341
16.4.2. ALMIRALL S.A.: COMPANY SNAPSHOT 341
16.4.3. PRODUCT PORTFOLIO 342
16.4.4. RECENT DEVELOPMENTS 342
16.5. VALEANT PHARMACEUTICALS INTERNATIONAL 343
16.5.1. COMPANY OVERVIEW 343
16.5.2. VALEANT PHARMACEUTICALS INTERNATIONAL: REVENUE ANALYSIS 343
16.5.3. PRODUCT PORTFOLIO 344
16.5.4. RECENT DEVELOPMENTS 344
16.6. ZYLERA PHARMACEUTICALS 345
16.6.1. COMPANY OVERVIEW 345
16.6.2. ZYLERA PHARMACEUTICALS: COMPANY SNAPSHOT 345
16.6.3. PRODUCT PORTFOLIO 346
16.6.4. RECENT DEVELOPMENTS 346
16.7. SANDOZ INTERNATIONAL GMBH 347
16.7.1. COMPANY OVERVIEW 347
16.7.2. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS 347
16.7.3. PRODUCT PORTFOLIO 348
16.7.4. RECENT DEVELOPMENTS 348
16.8. PFIZER INC. 349
16.8.1. COMPANY OVERVIEW 349
16.8.2. PFIZER INC.: REVENUE ANALYSIS 349
16.8.3. PRODUCT PORTFOLIO 350
16.8.4. RECENT DEVELOPMENTS 350
16.9. SANOFI S.A. 351
16.9.1. COMPANY OVERVIEW 351
16.9.2. SANOFI S.A.: COMPANY REVENUE ANALYSIS 351
16.9.3. PRODUCT PORTFOLIO 352
16.9.4. RECENT DEVELOPMENTS 352
16.10. ASTRAZENECA 353
16.10.1. COMPANY OVERVIEW 353
16.10.2. ASTRAZENECA: REVENUE ANALYSIS 353
16.10.3. PRODUCT PORTFOLIO 354
16.10.4. RECENT DEVELOPMENTS 354
17. RELATED REPORTS 355
List of Figures, Tables and Charts Available in Asia Pacific Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
TABLE LISTTABLE 1 PRICE OF VARIOUS PRODUCTS CONTAINING TOPICAL CORTICOSTEROIDS AND ANTIMICROBIALS 52
TABLE 2 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 61
TABLE 3 ASIA PACIFIC FLUDROXYCORTIDE MARKET, BY REGION,
2015– 2024 (USD MILLION) 62
TABLE 4 ASIA PACIFIC TRIAMCINOLONE ACETONIDE MARKET, BY REGION,
2015– 2024 (USD MILLION) 63
TABLE 5 ASIA PACIFIC FLUOCINOLONE ACETONIDE MARKET, BY REGION,
2015– 2024 (USD MILLION) 64
TABLE 6 ASIA PACIFIC ANTISEPTICS MARKET, BY REGION, 2015– 2024 (USD MILLION) 65
TABLE 7 ASIA PACIFIC BETAMETHASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 66
TABLE 8 ASIA PACIFIC CLOBETASONE PROPIONATE MARKET, BY REGION,
2015– 2024 (USD MILLION) 67
TABLE 9 ASIA PACIFIC CLOBETASONE BUTYRATE MARKET, BY REGION,
2015– 2024 (USD MILLION) 68
TABLE 10 ASIA PACIFIC HALOBETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 69
TABLE 11 ASIA PACIFIC MOMETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 70
TABLE 12 ASIA PACIFIC OTHERS MARKET, BY REGION, 2015– 2024 (USD MILLION) 71
TABLE 13 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 74
TABLE 14 ASIA PACIFIC ULTRA HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015-2024 (USD MILLION) 75
TABLE 15 ASIA PACIFIC ULTRA HIGH POTENCY CLASS MARKET, BY TYPE,
2015– 2024 (USD MILLION) 76
TABLE 16 ASIA PACIFIC HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 77
TABLE 17 ASIA PACIFIC HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 78
TABLE 18 ASIA PACIFIC MODERATE TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 79
TABLE 19 ASIA PACIFIC MODERATE HIGH POTENCY CLASS MARKET, BY TYPE,
2015– 2024 (USD MILLION) 80
TABLE 20 ASIA PACIFIC MILD TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 82
TABLE 21 ASIA PACIFIC MILD POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 83
TABLE 22 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 87
TABLE 23 ASIA PACIFIC ACNE TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 88
TABLE 24 ASIA PACIFIC DERMATITIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 89
TABLE 25 ASIA PACIFIC PSORIASIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 90
TABLE 26 ASIA PACIFIC SKIN INFECTION TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 91
TABLE 27 ASIA PACIFIC HYPERPIGMENTATION TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 92
TABLE 28 ASIA PACIFIC MELASMA TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 93
TABLE 29 ASIA PACIFIC OTHERS TOPICAL CORTICOSTEROIDS APPLICATION MARKET,
BY REGION, 2015 – 2024 (USD BILLION) 94
TABLE 30 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015– 2024 (USD MILLION) 97
TABLE 31 ASIA PACIFIC OINTMENT TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015-2024 (USD MILLION) 98
TABLE 32 ASIA PACIFIC CREAMS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 99
TABLE 33 ASIA PACIFIC LIQUID & SOLUTIONS TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 100
TABLE 34 ASIA PACIFIC LOTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 101
TABLE 35 ASIA PACIFIC GEL TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 102
TABLE 36 ASIA PACIFIC OILS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 103
TABLE 37 ASIA PACIFIC PASTES TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 104
TABLE 38 ASIA PACIFIC SPRAYS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 105
TABLE 39 ASIA PACIFIC OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 106
TABLE 40 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015– 2024 (USD MILLION) 109
TABLE 41 ASIA PACIFIC HOSPITAL TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 110
TABLE 42 ASIA PACIFIC DERMATOLOGY CLINICS TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 111
TABLE 43 ASIA PACIFIC HOMECARE TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 112
TABLE 44 ASIA PACIFIC OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 113
TABLE 45 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) 116
TABLE 46 ASIA PACIFIC HOSPITAL PHARMACIES TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 117
TABLE 47 ASIA PACIFIC PHARMACY STORES TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 118
TABLE 48 ASIA PACIFIC ONLINE PHARMACIES TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 119
TABLE 49 ASIA PACIFIC OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 120
TABLE 50 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 123
TABLE 51 ASIA PACIFIC OVER THE COUNTER (OTC) BASED TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) 124
TABLE 52 ASIA PACIFIC PRESCRIPTION BASED TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 125
TABLE 53 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY,
2015 – 2024 (USD MILLION) 137
TABLE 54 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY,
2015 – 2024 (USD MILLION) 236
TABLE 55 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 237
TABLE 56 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 238
TABLE 57 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 238
TABLE 58 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 239
TABLE 59 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 240
TABLE 60 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 240
TABLE 61 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 241
TABLE 62 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 242
TABLE 63 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE ,
2015 – 2024 (USD MILLION) 243
TABLE 64 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 243
TABLE 65 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015 – 2024 (USD MILLION) 244
TABLE 66 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 245
TABLE 67 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 245
TABLE 68 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 246
TABLE 69 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 247
TABLE 70 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE ,
2015 – 2024 (USD MILLION) 248
TABLE 71 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 248
TABLE 72 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015 – 2024 (USD MILLION) 249
TABLE 73 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 250
TABLE 74 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 251
TABLE 75 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 252
TABLE 76 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 253
TABLE 77 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE ,
2015 – 2024 (USD MILLION) 254
TABLE 78 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 254
TABLE 79 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015 – 2024 (USD MILLION) 255
TABLE 80 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 256
TABLE 81 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 257
TABLE 82 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 258
TABLE 83 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 259
TABLE 84 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 260
TABLE 85 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 260
TABLE 86 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 261
TABLE 87 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 262
TABLE 88 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 262
TABLE 89 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 263
TABLE 90 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 264
TABLE 91 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 265
TABLE 92 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 265
TABLE 93 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015 – 2024 (USD MILLION) 266
TABLE 94 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 267
TABLE 95 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 267
TABLE 96 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 268
TABLE 97 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 269
TABLE 98 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 270
TABLE 99 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 270
TABLE 100 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 271
TABLE 101 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 272
TABLE 102 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 272
TABLE 103 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 273
TABLE 104 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 274
TABLE 105 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE ,
2015 – 2024 (USD MILLION) 275
TABLE 106 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 275
TABLE 107 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015 – 2024 (USD MILLION) 276
TABLE 108 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 277
TABLE 109 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 277
TABLE 110 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 278
TABLE 111 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 279
TABLE 112 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE ,
2015 – 2024 (USD MILLION) 280
TABLE 113 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 280
TABLE 114 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015 – 2024 (USD MILLION) 281
TABLE 115 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 282
TABLE 116 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 282
TABLE 117 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 283
TABLE 118 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 284
TABLE 119 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 285
TABLE 120 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 285
TABLE 121 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015 – 2024 (USD MILLION) 286
TABLE 122 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 287
TABLE 123 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 287
TABLE 124 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 288
TABLE 125 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 289
TABLE 126 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 289
TABLE 127 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 290
TABLE 128 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 290
TABLE 129 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015 – 2024 (USD MILLION) 292
TABLE 130 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015 – 2024 (USD MILLION) 292
TABLE 131 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 293
TABLE 132 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015 – 2024 (USD MILLION) 294
FIGURES LIST
FIGURE 1 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: SEGMENTATION 38
FIGURE 2 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: DATA TRIANGULATION 42
FIGURE 3 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: RESEARCH SNAPSHOT 43
FIGURE 4 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET : BOTTOM UP APPROACH 45
FIGURE 5 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET : TOP DOWN APPROACH 45
FIGURE 6 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: INTERVIEW DEMOGRAPHICS 46
FIGURE 7 ASIA PACIFIC IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR TOPICAL CORTICOSTEROIDS MANUFACTURERS IN THE FORECAST PERIOD 2017 TO 2024 58
FIGURE 8 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY MOLECULE NAME, SNAPSHOT 2016 60
FIGURE 9 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY POTENCY CLASS, 2016 73
FIGURE 10 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY APPLICATION, 2016 86
FIGURE 11 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY MEDICATION TYPE, 2016 96
FIGURE 12 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY END-USER, 2016 108
FIGURE 13 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET:
BY DISTRIBUTION CHANNEL, 2016 115
FIGURE 14 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY PURCHASE MODE, 2016 122
FIGURE 15 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) 132
FIGURE 16 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016) 133
FIGURE 17 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY GROGRAPHY (2017 & 2024) 134
FIGURE 18 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016 & 2024) 135
FIGURE 19 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET,
BY MOLECULE NAME (2017 & 2024) 136
FIGURE 20 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) 231
FIGURE 21 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY COUNTRY (2016) 232
FIGURE 22 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET:
BY COUNTRY (2017 & 2024) 233
FIGURE 23 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET
BY COUNTRY (2016 & 2024) 234
FIGURE 24 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET,
BY MOLECULE NAME (2017 & 2024) 235
FIGURE 25 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%) 331
FIGURE 26 ASIA PACOFIC TOPICAL CORTICOSTEROIDS MARKET:
COMPANY SHARE 2016 (%) 334
Keyplayers in Asia Pacific Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
• LEO Pharma• Glaxosmithkline Plc,
• Pfizer Inc.
Request Sample
Request Discount
